Shopping Cart 0
Cart Subtotal
USD 0

Kineta Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Summary

Kineta Inc (Kineta) is a biotech company that develops novel immuno-therapies. The company offers small-molecule compounds that target RIG-I-like receptor pathways and intracellular IRF3-inducing pathways for applications in cancer. Its KCP-400 is a novel non-opioid therapy for the treatment of chronic pain. Kineta offers antiviral drugs such as LHF-535 for arena viruses including Lassa fever and innate immune antivirals. The company also develops pipeline products for the treatment of various therapeutic areas including respiratory syncytial virus, influenza, corona viruses, chronic pain, dengue virus, ebola, west nile virus, hepatitis b and c, and others. It has collaborations with academia, government and non-governmental organizations. Kineta is headquartered in Seattle, Washington, the US.

Kineta Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Kineta Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Kineta Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Kineta Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Kineta Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Kineta Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Kineta Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Kineta Four Acquires Lassa Fever Assets from SIGA Technologies 11

Venture Financing 12

Kineta Raises USD7 Million in Venture Financing 12

Kineta Raises Funds in Financing 13

Kineta Raises USD24.4 Million in Venture Financing 14

Kineta Raises USD5 Million in Venture Financing 15

Kineta Raises Funds through Venture Financing 16

Kineta Raises USD0.25 Million in Venture Financing 17

Kineta Raises USD1.8 Million in Venture Financing 18

Kineta Two Raises USD0.067 Million in Venture Financing 19

Kineta Raises USD1.6 Million in Venture Financing 20

KPI Therapeutics Raises USD1.6 Million in Venture Financing 21

Kineta Raises Funds Through Venture Financing 22

Kineta Two Raises USD 3 Million In Venture Financing 23

Private Equity 24

Hydra Invests In Kineta, Biotech Company 24

Partnerships 25

Kineta Enters into Contract with US Army Institute of Surgical Research 25

Kineta, KPI Therapeutics Enter into Partnership with UW Medicine and University of Washington 26

Kineta And RLB Enter Into Joint Venture Agreement To Form Kineta RLB 27

Licensing Agreements 28

Kineta Enters Into Licensing Agreement With University of Utah Research Foundation 28

Acquisition 29

RLB Acquires Minority Stake In Kineta 29

Kineta Inc-Key Competitors 30

Kineta Inc-Key Employees 31

Kineta Inc-Locations And Subsidiaries 32

Head Office 32

Other Locations & Subsidiaries 32

Recent Developments 33

Product News 33

04/05/2018: Kineta Immuno-oncology Unveils New Data Demonstrating Tumor Immunity in Multiple Tumor Models 33

03/23/2017: Kineta RLR Agonist Demonstrates Tumor Regression and an Adaptive Immune Response in Colon Carcinoma Model 34

01/22/2018: Kineta Immuno-oncology Announces Presentation on Novel RIG-I Agonists at Immuno-Oncology Frontiers World Conference 35

Clinical Trials 36

Feb 22, 2017: KCP-400 Relieves Chronic Pain and Demonstrates Disease Modifying Effects 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

Kineta Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Kineta Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Kineta Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Kineta Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Kineta Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Kineta Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Kineta Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Kineta Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9


List Of Table

List of Tables

Kineta Inc, Pharmaceuticals & Healthcare, Key Facts 2

Kineta Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Kineta Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Kineta Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Kineta Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Kineta Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Kineta Four Acquires Lassa Fever Assets from SIGA Technologies 11

Kineta Raises USD7 Million in Venture Financing 12

Kineta Raises Funds in Financing 13

Kineta Raises USD24.4 Million in Venture Financing 14

Kineta Raises USD5 Million in Venture Financing 15

Kineta Raises Funds through Venture Financing 16

Kineta Raises USD0.25 Million in Venture Financing 17

Kineta Raises USD1.8 Million in Venture Financing 18

Kineta Two Raises USD0.067 Million in Venture Financing 19

Kineta Raises USD1.6 Million in Venture Financing 20

KPI Therapeutics Raises USD1.6 Million in Venture Financing 21

Kineta Raises Funds Through Venture Financing 22

Kineta Two Raises USD 3 Million In Venture Financing 23

Hydra Invests In Kineta, Biotech Company 24

Kineta Enters into Contract with US Army Institute of Surgical Research 25

Kineta, KPI Therapeutics Enter into Partnership with UW Medicine and University of Washington 26

Kineta And RLB Enter Into Joint Venture Agreement To Form Kineta RLB 27

Kineta Enters Into Licensing Agreement With University of Utah Research Foundation 28

RLB Acquires Minority Stake In Kineta 29

Kineta Inc, Key Competitors 30

Kineta Inc, Key Employees 31

Kineta Inc, Subsidiaries 32

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com